Srikripa Devarakonda
Stock Analyst at Truist Securities
(0.67)
# 2177
Out of 5,255 analysts
66
Total ratings
31.91%
Success rate
-0.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceut... | Maintains: Buy | 1004 975 | 602.46 | 61.84% | 6 | Apr 23, 2025 | |
KROS Keros Therapeutics | Maintains: Buy | 43 25 | 14.16 | 76.55% | 5 | Apr 9, 2025 | |
INCY Incyte | Maintains: Hold | 74 72 | 59.19 | 21.64% | 9 | Mar 18, 2025 | |
PTGX Protagonist Therapeu... | Maintains: Strong Buy | 60 76 | 44.48 | 70.86% | 2 | Mar 11, 2025 | |
BIIB Biogen | Maintains: Buy | 220 210 | 118.87 | 76.66% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 1029 1038 | 884.52 | 17.35% | 4 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 211 217 | 186.34 | 16.45% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 32 | 22.96 | 39.37% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 14.87 | 236.25% | 6 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 36 45 | 32.79 | 37.24% | 4 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 54 53 | 33.26 | 59.35% | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 54 54 | 2.17 | 2388.48% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 7.48 | 100.53% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 36 | 11.57 | 211.15% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 70 | 40.44 | 73.1% | 4 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 60 | 0.96 | 6150% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 50 34 | n/a | n/a | 2 | Jun 3, 2021 |